Back
Arcturus Therapeutics Holdings, Inc. Stock Predictions
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
23
ARCT
Arcturus Therapeutics Holdings, Inc.
Last Price:
$7.17
Seasonality Move:
-0.86%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiArcturus Therapeutics Holdings, Inc. Stock Forecast
-
Over the next 52 weeks, Arcturus Therapeutics Holdings, Inc. has on average historically risen by 44.8% based on the past 12 years of stock performance.
-
Arcturus Therapeutics Holdings, Inc. has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Arcturus Therapeutics Holdings, Inc. Stock Undervalued?The current Arcturus Therapeutics Holdings, Inc. [ARCT] share price is $7.46. The Score for ARCT is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
ARCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Arcturus Therapeutics Holdings, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Arcturus Therapeutics Holdings, Inc. has on average historically risen by 44.8% based on the past 12 years of stock performance.
Arcturus Therapeutics Holdings, Inc. Stock Rating
Sell
23
Arcturus Therapeutics Holdings, Inc. (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings, Inc. overpriced?
-
Arcturus Therapeutics Holdings, Inc. has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Arcturus Therapeutics Holdings, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com
52-Week Data
52-Week High:
24.17
52-Week Low:
5.85
Prediction Charts
Market Cap:
212M
Price in USD:
7.46
Volume:
683.7K
Beta:
2.50
Technical Analysis
SMA50:
11.42
SMA100:
14.21
SMA200:
13.40
52-Wk Change:
-57.49%
Stock Predictions
-
Is Arcturus Therapeutics Holdings, Inc. stock public?Yes, Arcturus Therapeutics Holdings, Inc. is a publicly traded company.
-
What is the Arcturus Therapeutics Holdings, Inc. stock quote today?The Arcturus Therapeutics Holdings, Inc. stock price is 7.46 USD today.
-
How to buy Arcturus Therapeutics Holdings, Inc. stock online?You can buy Arcturus Therapeutics Holdings, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-24 | 6.28 | 6.33 | 6.38 | 6.07 |
| Nov-25 | 6.43 | 6.80 | 6.84 | 6.32 |
| Nov-26 | 6.83 | 6.80 | 6.90 | 6.60 |
| Nov-28 | 6.83 | 6.79 | 6.90 | 6.75 |
| Dec-1 | 6.62 | 6.49 | 6.75 | 6.35 |
| Dec-2 | 6.51 | 6.25 | 6.51 | 6.07 |
| Dec-3 | 6.30 | 6.59 | 6.61 | 6.23 |
| Dec-4 | 6.54 | 6.83 | 6.85 | 6.47 |
| Dec-5 | 6.85 | 7.13 | 7.19 | 6.84 |
| Dec-8 | 7.17 | 7.45 | 7.74 | 7.00 |
| Dec-9 | 7.39 | 7.20 | 7.46 | 7.17 |
| Dec-10 | 7.21 | 7.67 | 7.68 | 7.04 |
| Dec-11 | 7.65 | 7.52 | 7.76 | 7.47 |
| Dec-12 | 7.52 | 7.46 | 7.62 | 7.33 |
Arcturus Therapeutics Holdings, Inc. Earnings
Arcturus Therapeutics Holdings, Inc. Earnings Report: Per Share Arcturus Therapeutics Holdings, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcturus Therapeutics Holdings, Inc. Forecast Revenue Growth
Arcturus Therapeutics Holdings, Inc. Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.43 per share.
* Arcturus Therapeutics Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.